451 related articles for article (PubMed ID: 30200181)
1. Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.
Floresta G; Apirakkan O; Rescifina A; Abbate V
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200181
[TBL] [Abstract][Full Text] [Related]
2. 7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists.
Rempel V; Volz N; Hinz S; Karcz T; Meliciani I; Nieger M; Wenzel W; Bräse S; Müller CE
J Med Chem; 2012 Sep; 55(18):7967-77. PubMed ID: 22916707
[TBL] [Abstract][Full Text] [Related]
3. Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands.
Floresta G; Rescifina A; Marrazzo A; Dichiara M; Pistarà V; Pittalà V; Prezzavento O; Amata E
Eur J Med Chem; 2017 Oct; 139():884-891. PubMed ID: 28866257
[TBL] [Abstract][Full Text] [Related]
4. 3D-QSAR/CoMFA-based structure-affinity/selectivity relationships of aminoalkylindoles in the cannabinoid CB1 and CB2 receptors.
Mella-Raipán J; Hernández-Pino S; Morales-Verdejo C; Pessoa-Mahana D
Molecules; 2014 Mar; 19(3):2842-61. PubMed ID: 24603555
[TBL] [Abstract][Full Text] [Related]
5. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T
J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177
[TBL] [Abstract][Full Text] [Related]
6. In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach.
Khan N; Halim SA; Khan W; Zafar SK; Ul-Haq Z
J Mol Graph Model; 2019 Jun; 89():199-214. PubMed ID: 30908997
[TBL] [Abstract][Full Text] [Related]
7. Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
Romero-Parra J; Chung H; Tapia RA; Faúndez M; Morales-Verdejo C; Lorca M; Lagos CF; Di Marzo V; David Pessoa-Mahana C; Mella J
Eur J Pharm Sci; 2017 Apr; 101():1-10. PubMed ID: 28137469
[TBL] [Abstract][Full Text] [Related]
8. The bioisosteric concept applied to cannabinoid ligands.
Mugnaini C; Pasquini S; Corelli F
Curr Med Chem; 2012; 19(28):4794-815. PubMed ID: 22830341
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.
Chen JZ; Han XW; Liu Q; Makriyannis A; Wang J; Xie XQ
J Med Chem; 2006 Jan; 49(2):625-36. PubMed ID: 16420048
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB
Aviz-Amador A; Contreras-Puentes N; Mercado-Camargo J
Comput Biol Chem; 2021 Dec; 95():107590. PubMed ID: 34700256
[TBL] [Abstract][Full Text] [Related]
11. An effort to discover the preferred conformation of the potent AMG3 cannabinoid analog when reaching the active sites of the cannabinoid receptors.
Durdagi S; Papadopoulos MG; Mavromoustakos T
Eur J Med Chem; 2012 Jan; 47(1):44-51. PubMed ID: 22071252
[TBL] [Abstract][Full Text] [Related]
12. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
Shim JY; Welsh WJ; Howlett AC
Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
Grey J; Terry P; Higgs S
Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
[TBL] [Abstract][Full Text] [Related]
14. Examining the critical roles of human CB2 receptor residues Valine 3.32 (113) and Leucine 5.41 (192) in ligand recognition and downstream signaling activities.
Alqarni M; Myint KZ; Tong Q; Yang P; Bartlow P; Wang L; Feng R; Xie XQ
Biochem Biophys Res Commun; 2014 Sep; 452(3):334-9. PubMed ID: 25148941
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of the Human Cannabinoid Receptor CB2.
Li X; Hua T; Vemuri K; Ho JH; Wu Y; Wu L; Popov P; Benchama O; Zvonok N; Locke K; Qu L; Han GW; Iyer MR; Cinar R; Coffey NJ; Wang J; Wu M; Katritch V; Zhao S; Kunos G; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
Cell; 2019 Jan; 176(3):459-467.e13. PubMed ID: 30639103
[TBL] [Abstract][Full Text] [Related]
16. Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity.
Durdagi S; Papadopoulos MG; Papahatjis DP; Mavromoustakos T
Bioorg Med Chem Lett; 2007 Dec; 17(24):6754-63. PubMed ID: 17980589
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Brogi S; Corelli F; Di Marzo V; Ligresti A; Mugnaini C; Pasquini S; Tafi A
Eur J Med Chem; 2011 Feb; 46(2):547-55. PubMed ID: 21183257
[TBL] [Abstract][Full Text] [Related]
18. New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking.
Ragusa G; Gómez-Cañas M; Morales P; Rodríguez-Cueto C; Pazos MR; Asproni B; Cichero E; Fossa P; Pinna GA; Jagerovic N; Fernández-Ruiz J; Murineddu G
Eur J Med Chem; 2017 Feb; 127():398-412. PubMed ID: 28088085
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis.
Floresta G; Amata E; Dichiara M; Marrazzo A; Salerno L; Romeo G; Prezzavento O; Pittalà V; Rescifina A
ChemMedChem; 2018 Jul; 13(13):1336-1342. PubMed ID: 29693778
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation and binding mode modeling of benzimidazole derivatives targeting the cannabinoid receptor type 1.
Espinosa-Bustos C; Lagos CF; Romero-Parra J; Zárate AM; Mella-Raipán J; Pessoa-Mahana H; Recabarren-Gajardo G; Iturriaga-Vásquez P; Tapia RA; Pessoa-Mahana CD
Arch Pharm (Weinheim); 2015 Feb; 348(2):81-8. PubMed ID: 25641513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
